Nrf2 signaling pathway in chemoprotection and doxorubicin resistance: potential application in drug discovery
10.3390/antiox10030349
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Review |
| Published: |
MDPI
2022
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/232508 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-232508 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-2325082024-04-04T04:01:35Z Nrf2 signaling pathway in chemoprotection and doxorubicin resistance: potential application in drug discovery Mirzaei, Sepideh Zarrabi, Ali Hashemi, Farid Zabolian, Amirhossein Saleki, Hossein Azami, Negar Hamzehlou, Soodeh Farahani, Mahdi Vasheghani Hushmandi, Kiavash Ashrafizadeh, Milad Khan, Haroon Kumar, Alan Prem PHARMACOLOGY Chemoresistance Doxorubicin Nuclear factor erythroid 2?related factor 2 (Nrf2), cancer therapy Oxidative stress Redox signaling 10.3390/antiox10030349 Antioxidants 10 3 Jan-27 2022-10-12T08:09:15Z 2022-10-12T08:09:15Z 2021-02-26 Review Mirzaei, Sepideh, Zarrabi, Ali, Hashemi, Farid, Zabolian, Amirhossein, Saleki, Hossein, Azami, Negar, Hamzehlou, Soodeh, Farahani, Mahdi Vasheghani, Hushmandi, Kiavash, Ashrafizadeh, Milad, Khan, Haroon, Kumar, Alan Prem (2021-02-26). Nrf2 signaling pathway in chemoprotection and doxorubicin resistance: potential application in drug discovery. Antioxidants 10 (3) : Jan-27. ScholarBank@NUS Repository. https://doi.org/10.3390/antiox10030349 2076-3921 https://scholarbank.nus.edu.sg/handle/10635/232508 Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/ MDPI Scopus OA2021 |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| topic |
Chemoresistance Doxorubicin Nuclear factor erythroid 2?related factor 2 (Nrf2), cancer therapy Oxidative stress Redox signaling |
| spellingShingle |
Chemoresistance Doxorubicin Nuclear factor erythroid 2?related factor 2 (Nrf2), cancer therapy Oxidative stress Redox signaling Mirzaei, Sepideh Zarrabi, Ali Hashemi, Farid Zabolian, Amirhossein Saleki, Hossein Azami, Negar Hamzehlou, Soodeh Farahani, Mahdi Vasheghani Hushmandi, Kiavash Ashrafizadeh, Milad Khan, Haroon Kumar, Alan Prem Nrf2 signaling pathway in chemoprotection and doxorubicin resistance: potential application in drug discovery |
| description |
10.3390/antiox10030349 |
| author2 |
PHARMACOLOGY |
| author_facet |
PHARMACOLOGY Mirzaei, Sepideh Zarrabi, Ali Hashemi, Farid Zabolian, Amirhossein Saleki, Hossein Azami, Negar Hamzehlou, Soodeh Farahani, Mahdi Vasheghani Hushmandi, Kiavash Ashrafizadeh, Milad Khan, Haroon Kumar, Alan Prem |
| format |
Review |
| author |
Mirzaei, Sepideh Zarrabi, Ali Hashemi, Farid Zabolian, Amirhossein Saleki, Hossein Azami, Negar Hamzehlou, Soodeh Farahani, Mahdi Vasheghani Hushmandi, Kiavash Ashrafizadeh, Milad Khan, Haroon Kumar, Alan Prem |
| author_sort |
Mirzaei, Sepideh |
| title |
Nrf2 signaling pathway in chemoprotection and doxorubicin resistance: potential application in drug discovery |
| title_short |
Nrf2 signaling pathway in chemoprotection and doxorubicin resistance: potential application in drug discovery |
| title_full |
Nrf2 signaling pathway in chemoprotection and doxorubicin resistance: potential application in drug discovery |
| title_fullStr |
Nrf2 signaling pathway in chemoprotection and doxorubicin resistance: potential application in drug discovery |
| title_full_unstemmed |
Nrf2 signaling pathway in chemoprotection and doxorubicin resistance: potential application in drug discovery |
| title_sort |
nrf2 signaling pathway in chemoprotection and doxorubicin resistance: potential application in drug discovery |
| publisher |
MDPI |
| publishDate |
2022 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/232508 |
| _version_ |
1800915617486733312 |